NewGenIvf prices $1.25 million public offering at $0.07 per share
The deal covers 17,857,143 ordinary shares or pre-funded warrants in lieu of shares. Closing is expected on or about Sept. 30, 2026, subject to customary conditions.
The deal covers 17,857,143 ordinary shares or pre-funded warrants in lieu of shares. Closing is expected on or about Sept. 30, 2026, subject to customary conditions.